MICROVISION, INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $MVIS in the last 30 days.
See all $MVIS insider activity →Microvision (MVIS) shares fell 9.2% in after-hours trading after reaffirming 2026 revenue guidance of $10M-$15M without an increase, disappointing investors. Q2 2026 revenue was $1.47M with a net loss of $36.9M. Management highlighted a drone lidar partnership and cost-saving plans for 2027, but concerns over revenue growth and cash burn persisted. The broader market was unchanged, indicating the drop was company-specific.
MICROVISION, INC. (MVIS) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 MicroVision Reaffirms 2026 Revenue Outlook, Outlines Commercial Growth, and Path to Profitability Company conveys confidence in 2026 revenue guidance, doubling of revenue in 2027, and significant reduction in cash burn as commercial strategy drives operations and cap
MicroVision (MVIS) reaffirmed its 2026 revenue guidance of $10M–$15M and projected 2027 revenue to double, with plans for cost savings and reduced cash burn. The company is shifting to a diversified revenue model.
Over the past 7 days, AlphAI's AI scored 8 news stories mentioning MVIS (MICROVISION, INC.). Coverage has skewed bearish: 1 bullish, 4 neutral, and 3 bearish.
Recent MVIS coverage spans market movers, financial news and technology.
Shares fell sharply as investors received no upside guidance despite a revenue outlook.
Reaffirmed guidance may support modest upside if investors value the growth outlook.
Guidance remains low and modest growth expectations may keep the stock under pressure.
The partnership signals entry into defense and industrial lidar markets, which could lift sentiment but lacks immediate revenue.
Selection supports MicroVision’s defense commercialization narrative, but details are confidential and no contract value or timeline is disclosed.
AlphAI scores every news story that mentions MVIS with an AI model for sentiment and relevance, and aggregates insider trades from MICROVISION, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Microvision (MVIS) shares fell 9.2% in after-hours trading after reaffirming 2026 revenue guidance of $10M-$15M without an increase, disappointing investors. Q2 2026 revenue was $1.47M with a net loss of $36.9M. Management highlighted a drone lidar partnership and cost-saving plans for 2027, but concerns over revenue growth and cash burn persisted. The broader market was unchanged, indicating the drop was company-specific.
2 min readMICROVISION, INC. (MVIS) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 MicroVision Reaffirms 2026 Revenue Outlook, Outlines Commercial Growth, and Path to Profitability Company conveys confidence in 2026 revenue guidance, doubling of revenue in 2027, and significant reduction in cash burn as commercial strategy drives operations and cap
2 min readMicroVision (MVIS) reaffirmed its 2026 revenue guidance of $10M–$15M and projected 2027 revenue to double, with plans for cost savings and reduced cash burn. The company is shifting to a diversified revenue model.
1 min readMicroVision (MVIS) partnered with Robinson Unmanned to integrate MOVIA Air Plus lidar on the Blue UAS-cleared SPIRIT platform. Demos and customer evaluations are planned. This aligns with MVIS's strategy to expand lidar use in defense and industrial sectors.
1 min readMicroVision's IRIS long-range lidar sensor has been chosen for integration into autonomous ground vehicle systems for defense applications. The selection follows an evaluation for high-performance perception in challenging environments. MicroVision's CEO highlighted the validation of IRIS's capabilities in demanding defense settings. The company continues to expand in security & defense, industrial, and automotive markets.
3 min readMicroVision (MVIS) announced its IRIS long-range lidar will support an autonomous mobility service pilot in the Asia-Pacific region. The technology integrates with cameras and radar for real-time environmental sensing. CEO Glen DeVos highlighted the progression from evaluation to real-world deployment, emphasizing the value of the Luminar assets acquisition. The program may transition to MicroVision's next-generation HALO sensor as it scales.
2 min readMicroVision (NASDAQ: MVIS) granted 674,536 and 562,114 restricted stock units to its new Chief Commercial Officer and Chief Financial Officer, respectively. The units vest over four years, contingent on continued service. The grants were made under the company's 2025 Inducement Equity Incentive Plan.
2 min readMicroVision (NASDAQ: MVIS) granted 674,536 RSUs to its new Chief Commercial Officer and 562,114 RSUs to its new CFO. The RSUs vest over four years, subject to continued service.
1 min readMicroVision (MVIS) stock rose 11% after announcing a partnership with an unnamed industrial equipment manufacturer to develop lidar technologies. The agreement involves installing Iris lidar sensors on off-highway trucks, with potential for further integration. Financial details were not disclosed. MVIS has underperformed, down 55% YTD and 70% over 12 months.
2 min readFulcrum Therapeutics (FULC) fell 51% to a 52-week low of $2.9 after halting development of its lead sickle cell disease treatment due to FDA cancer risk concerns. Heron Therapeutics (HRTX) dropped 45% to $0.44 following a court ruling invalidating key patents for CINVANTI. MicroVision (MVIS) declined 32% to $0.4 after proposing a reverse stock split to meet Nasdaq requirements.
2 min read
